Global Non-Tyrosine Kinase Inhibitors Market Analysis 2015-2019 and Forecast 2020-2025
- 99S3753803
- 114 Pages
- February 2020
- Healthcare
The global Non-Tyrosine Kinase Inhibitors market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Non-Tyrosine Kinase Inhibitors by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
mTOR Inhibitors
RAF/MEK Inhibitors
CDK Inhibitors
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Roche
Eli Lilly
Novartis
Array BioPharma
Nerviano Medical Sciences
Pfizer
Merck KGaA
Astex Pharmaceuticals
Cyclacel Pharmaceuticals
Daiichi Sankyo
Onconova Therapeutics
AstraZeneca
GlaxoSmithKline (GSK)
Carna Biosciences
Celgene Corporation
Eternity Bioscience
Jasco Pharmaceuticals
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Liver Cancer
Respiratory Cancer
Brain Cancer
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
1 Industry Overview
1.1 Non-Tyrosine Kinase Inhibitors Industry
Figure Non-Tyrosine Kinase Inhibitors Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Non-Tyrosine Kinase Inhibitors
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Non-Tyrosine Kinase Inhibitors
1.2.2 Downstream
Table Application Segment of Non-Tyrosine Kinase Inhibitors
Table Global Non-Tyrosine Kinase Inhibitors Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Non-Tyrosine Kinase Inhibitors Market by Type
3.1 By Type
3.1.1 mTOR Inhibitors
Table Major Company List of mTOR Inhibitors
3.1.2 RAF/MEK Inhibitors
Table Major Company List of RAF/MEK Inhibitors
3.1.3 CDK Inhibitors
Table Major Company List of CDK Inhibitors
3.2 Market Size
Table Global Non-Tyrosine Kinase Inhibitors Market 2015-2019, by Type, in USD Million
Figure Global Non-Tyrosine Kinase Inhibitors Market Growth 2015-2019, by Type, in USD Million
Table Global Non-Tyrosine Kinase Inhibitors Market 2015-2019, by Type, in Volume
Figure Global Non-Tyrosine Kinase Inhibitors Market Growth 2015-2019, by Type, in Volume
3.3 Market Forecast
Table Global Non-Tyrosine Kinase Inhibitors Market Forecast 2020-2025, by Type, in USD Million
Table Global Non-Tyrosine Kinase Inhibitors Market Forecast 2020-2025, by Type, in Volume
4 Major Companies List
4.1 Roche (Company Profile, Sales Data etc.)
4.1.1 Roche Profile
Table Roche Overview List
4.1.2 Roche Products & Services
4.1.3 Roche Business Operation Conditions
Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Eli Lilly (Company Profile, Sales Data etc.)
4.2.1 Eli Lilly Profile
Table Eli Lilly Overview List
4.2.2 Eli Lilly Products & Services
4.2.3 Eli Lilly Business Operation Conditions
Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Novartis (Company Profile, Sales Data etc.)
4.3.1 Novartis Profile
Table Novartis Overview List
4.3.2 Novartis Products & Services
4.3.3 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Array BioPharma (Company Profile, Sales Data etc.)
4.4.1 Array BioPharma Profile
Table Array BioPharma Overview List
4.4.2 Array BioPharma Products & Services
4.4.3 Array BioPharma Business Operation Conditions
Table Business Operation of Array BioPharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Nerviano Medical Sciences (Company Profile, Sales Data etc.)
4.5.1 Nerviano Medical Sciences Profile
Table Nerviano Medical Sciences Overview List
4.5.2 Nerviano Medical Sciences Products & Services
4.5.3 Nerviano Medical Sciences Business Operation Conditions
Table Business Operation of Nerviano Medical Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Pfizer (Company Profile, Sales Data etc.)
4.6.1 Pfizer Profile
Table Pfizer Overview List
4.6.2 Pfizer Products & Services
4.6.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Merck KGaA (Company Profile, Sales Data etc.)
4.7.1 Merck KGaA Profile
Table Merck KGaA Overview List
4.7.2 Merck KGaA Products & Services
4.7.3 Merck KGaA Business Operation Conditions
Table Business Operation of Merck KGaA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Astex Pharmaceuticals (Company Profile, Sales Data etc.)
4.8.1 Astex Pharmaceuticals Profile
Table Astex Pharmaceuticals Overview List
4.8.2 Astex Pharmaceuticals Products & Services
4.8.3 Astex Pharmaceuticals Business Operation Conditions
Table Business Operation of Astex Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Cyclacel Pharmaceuticals (Company Profile, Sales Data etc.)
4.9.1 Cyclacel Pharmaceuticals Profile
Table Cyclacel Pharmaceuticals Overview List
4.9.2 Cyclacel Pharmaceuticals Products & Services
4.9.3 Cyclacel Pharmaceuticals Business Operation Conditions
Table Business Operation of Cyclacel Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Daiichi Sankyo (Company Profile, Sales Data etc.)
4.10.1 Daiichi Sankyo Profile
Table Daiichi Sankyo Overview List
4.10.2 Daiichi Sankyo Products & Services
4.10.3 Daiichi Sankyo Business Operation Conditions
Table Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Onconova Therapeutics (Company Profile, Sales Data etc.)
4.11.1 Onconova Therapeutics Profile
Table Onconova Therapeutics Overview List
4.11.2 Onconova Therapeutics Products & Services
4.11.3 Onconova Therapeutics Business Operation Conditions
Table Business Operation of Onconova Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 AstraZeneca (Company Profile, Sales Data etc.)
4.12.1 AstraZeneca Profile
Table AstraZeneca Overview List
4.12.2 AstraZeneca Products & Services
4.12.3 AstraZeneca Business Operation Conditions
Table Business Operation of AstraZeneca (Sales Revenue, Cost, Gross Margin)
4.13 GlaxoSmithKline (GSK) (Company Profile, Sales Data etc.)
4.13.1 GlaxoSmithKline (GSK) Profile
Table GlaxoSmithKline (GSK) Overview List
4.13.2 GlaxoSmithKline (GSK) Products & Services
4.13.3 GlaxoSmithKline (GSK) Business Operation Conditions
Table Business Operation of GlaxoSmithKline (GSK) (Sales Revenue, Cost, Gross Margin)
4.14 Carna Biosciences (Company Profile, Sales Data etc.)
4.14.1 Carna Biosciences Profile
Table Carna Biosciences Overview List
4.14.2 Carna Biosciences Products & Services
4.14.3 Carna Biosciences Business Operation Conditions
Table Business Operation of Carna Biosciences (Sales Revenue, Cost, Gross Margin)
4.15 Celgene Corporation (Company Profile, Sales Data etc.)
4.15.1 Celgene Corporation Profile
Table Celgene Corporation Overview List
4.15.2 Celgene Corporation Products & Services
4.15.3 Celgene Corporation Business Operation Conditions
Table Business Operation of Celgene Corporation (Sales Revenue, Cost, Gross Margin)
4.16 Eternity Bioscience (Company Profile, Sales Data etc.)
4.16.1 Eternity Bioscience Profile
Table Eternity Bioscience Overview List
4.16.2 Eternity Bioscience Products & Services
4.16.3 Eternity Bioscience Business Operation Conditions
Table Business Operation of Eternity Bioscience (Sales Revenue, Cost, Gross Margin)
4.17 Jasco Pharmaceuticals (Company Profile, Sales Data etc.)
4.17.1 Jasco Pharmaceuticals Profile
Table Jasco Pharmaceuticals Overview List
4.17.2 Jasco Pharmaceuticals Products & Services
4.17.3 Jasco Pharmaceuticals Business Operation Conditions
Table Business Operation of Jasco Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Non-Tyrosine Kinase Inhibitors Sales Revenue 2015-2019, by Company, in USD Million
Table Global Non-Tyrosine Kinase Inhibitors Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global Non-Tyrosine Kinase Inhibitors Sales Revenue Share in 2019, by Company, in USD Million
Table Global Non-Tyrosine Kinase Inhibitors Sales Volume 2015-2019, by Company, in Volume
Table Global Non-Tyrosine Kinase Inhibitors Sales Volume Share 2015-2019, by Company, in Volume
Figure Global Non-Tyrosine Kinase Inhibitors Sales Volume Share in 2019, by Company, in Volume
5.2 Regional Market by Company
Figure North America Non-Tyrosine Kinase Inhibitors Market Concentration, in 2019
Figure Europe Non-Tyrosine Kinase Inhibitors Market Market Concentration, in 2019
Figure Asia-Pacific Non-Tyrosine Kinase Inhibitors MMarket Concentration, in 2019
Figure South America Non-Tyrosine Kinase Inhibitors Market Concentration, in 2019
Figure Middle East & Africa Non-Tyrosine Kinase Inhibitors Market Concentration, in 2019
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Liver Cancer
Figure Non-Tyrosine Kinase Inhibitors Demand in Liver Cancer, 2015-2019, in USD Million
Figure Non-Tyrosine Kinase Inhibitors Demand in Liver Cancer, 2015-2019, in Volume
6.1.2 Demand in Respiratory Cancer
Figure Non-Tyrosine Kinase Inhibitors Demand in Respiratory Cancer, 2015-2019, in USD Million
Figure Non-Tyrosine Kinase Inhibitors Demand in Respiratory Cancer, 2015-2019, in Volume
6.1.3 Demand in Brain Cancer
Figure Non-Tyrosine Kinase Inhibitors Demand in Brain Cancer, 2015-2019, in USD Million
Figure Non-Tyrosine Kinase Inhibitors Demand in Brain Cancer, 2015-2019, in Volume
6.1.4 Demand in Others
Figure Non-Tyrosine Kinase Inhibitors Demand in Others, 2015-2019, in USD Million
Figure Non-Tyrosine Kinase Inhibitors Demand in Others, 2015-2019, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Non-Tyrosine Kinase Inhibitors Demand Forecast 2020-2025, by Application, in USD Million
Figure Non-Tyrosine Kinase Inhibitors Market Growth 2020-2025, by Application, in USD Million
Figure Non-Tyrosine Kinase Inhibitors Market Share in 2025, by Application, in USD Million
Table Non-Tyrosine Kinase Inhibitors Demand Forecast 2020-2025, by Application, in Volume
Table Non-Tyrosine Kinase Inhibitors Market Growth 2020-2025, by Application, in Volume
Table Non-Tyrosine Kinase Inhibitors Market Share in 2025, by Application, in Volume
7 Region Operation
7.1 Regional Production
Table Non-Tyrosine Kinase Inhibitors Production 2015-2019, by Region, in USD Million
Table Non-Tyrosine Kinase Inhibitors Production 2015-2019, by Region, in Volume
7.2 Regional Market
Table Global Non-Tyrosine Kinase Inhibitors Market 2015-2019, by Region, in USD Million
Table Global Non-Tyrosine Kinase Inhibitors Market Share 2015-2019, by Region, in USD Million
Table Global Non-Tyrosine Kinase Inhibitors Market 2015-2019, by Region, in Volume
Table Global Non-Tyrosine Kinase Inhibitors Market Share 2015-2019, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Non-Tyrosine Kinase Inhibitors Market Size and Growth 2015-2019, in USD Million
Figure North America Non-Tyrosine Kinase Inhibitors Market Size and Growth 2015-2019, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Non-Tyrosine Kinase Inhibitors Market Size 2015-2019, by Country, in USD Million
Table North America Non-Tyrosine Kinase Inhibitors Market Size 2015-2019, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Non-Tyrosine Kinase Inhibitors Market Size and Growth 2015-2019, in USD Million
Figure Europe Non-Tyrosine Kinase Inhibitors Market Size and Growth 2015-2019, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Non-Tyrosine Kinase Inhibitors Market Size 2015-2019, by Country, in USD Million
Table Europe Non-Tyrosine Kinase Inhibitors Market Size 2015-2019, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Non-Tyrosine Kinase Inhibitors Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Non-Tyrosine Kinase Inhibitors Market Size and Growth 2015-2019, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Non-Tyrosine Kinase Inhibitors Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Non-Tyrosine Kinase Inhibitors Market Size 2015-2019, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Non-Tyrosine Kinase Inhibitors Market Size and Growth 2015-2019, in USD Million
Figure South America Non-Tyrosine Kinase Inhibitors Market Size and Growth 2015-2019, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Non-Tyrosine Kinase Inhibitors Market Size 2015-2019, by Country, in USD Million
Table South America Non-Tyrosine Kinase Inhibitors Market Size 2015-2019, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Non-Tyrosine Kinase Inhibitors Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Non-Tyrosine Kinase Inhibitors Market Size and Growth 2015-2019, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Non-Tyrosine Kinase Inhibitors Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Non-Tyrosine Kinase Inhibitors Market Size 2015-2019, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Non-Tyrosine Kinase Inhibitors Market Forecast 2020-2025, by Region, in USD Million
Table Non-Tyrosine Kinase Inhibitors Market Forecast 2020-2025, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
Table Upstream Segment of Non-Tyrosine Kinase Inhibitors
Table Application Segment of Non-Tyrosine Kinase Inhibitors
Table Global Non-Tyrosine Kinase Inhibitors Market 2015-2025, by Application, in USD Million
Table Major Company List of RAF/MEK Inhibitors
Table Major Company List of CDK Inhibitors
Table Global Non-Tyrosine Kinase Inhibitors Market 2015-2019, by Type, in USD Million
Table Global Non-Tyrosine Kinase Inhibitors Market 2015-2019, by Type, in Volume
Table Global Non-Tyrosine Kinase Inhibitors Market Forecast 2020-2025, by Type, in USD Million
Table Global Non-Tyrosine Kinase Inhibitors Market Forecast 2020-2025, by Type, in Volume
Table Roche Overview List
Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly Overview List
Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Array BioPharma Overview List
Table Business Operation of Array BioPharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Nerviano Medical Sciences Overview List
Table Business Operation of Nerviano Medical Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck KGaA Overview List
Table Business Operation of Merck KGaA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Astex Pharmaceuticals Overview List
Table Business Operation of Astex Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cyclacel Pharmaceuticals Overview List
Table Business Operation of Cyclacel Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daiichi Sankyo Overview List
Table Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Onconova Therapeutics Overview List
Table Business Operation of Onconova Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Business Operation of AstraZeneca (Sales Revenue, Cost, Gross Margin)
Table GlaxoSmithKline (GSK) Overview List
Table Business Operation of GlaxoSmithKline (GSK) (Sales Revenue, Cost, Gross Margin)
Table Carna Biosciences Overview List
Table Business Operation of Carna Biosciences (Sales Revenue, Cost, Gross Margin)
Table Celgene Corporation Overview List
Table Business Operation of Celgene Corporation (Sales Revenue, Cost, Gross Margin)
Table Eternity Bioscience Overview List
Table Business Operation of Eternity Bioscience (Sales Revenue, Cost, Gross Margin)
Table Jasco Pharmaceuticals Overview List
Table Business Operation of Jasco Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Global Non-Tyrosine Kinase Inhibitors Sales Revenue 2015-2019, by Company, in USD Million
Table Global Non-Tyrosine Kinase Inhibitors Sales Revenue Share 2015-2019, by Company, in USD Million
Table Global Non-Tyrosine Kinase Inhibitors Sales Volume 2015-2019, by Company, in Volume
Table Global Non-Tyrosine Kinase Inhibitors Sales Volume Share 2015-2019, by Company, in Volume
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Non-Tyrosine Kinase Inhibitors Demand Forecast 2020-2025, by Application, in USD Million
Table Non-Tyrosine Kinase Inhibitors Demand Forecast 2020-2025, by Application, in Volume
Table Non-Tyrosine Kinase Inhibitors Market Growth 2020-2025, by Application, in Volume
Table Non-Tyrosine Kinase Inhibitors Market Share in 2025, by Application, in Volume
Table Non-Tyrosine Kinase Inhibitors Production 2015-2019, by Region, in USD Million
Table Non-Tyrosine Kinase Inhibitors Production 2015-2019, by Region, in Volume
Table Global Non-Tyrosine Kinase Inhibitors Market 2015-2019, by Region, in USD Million
Table Global Non-Tyrosine Kinase Inhibitors Market Share 2015-2019, by Region, in USD Million
Table Global Non-Tyrosine Kinase Inhibitors Market 2015-2019, by Region, in Volume
Table Global Non-Tyrosine Kinase Inhibitors Market Share 2015-2019, by Region, in Volume
Table North America Non-Tyrosine Kinase Inhibitors Market Size 2015-2019, by Country, in USD Million
Table North America Non-Tyrosine Kinase Inhibitors Market Size 2015-2019, by Country, in Volume
Table Europe Non-Tyrosine Kinase Inhibitors Market Size 2015-2019, by Country, in USD Million
Table Europe Non-Tyrosine Kinase Inhibitors Market Size 2015-2019, by Country, in Volume
Table Asia-Pacific Non-Tyrosine Kinase Inhibitors Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Non-Tyrosine Kinase Inhibitors Market Size 2015-2019, by Country, in Volume
Table South America Non-Tyrosine Kinase Inhibitors Market Size 2015-2019, by Country, in USD Million
Table South America Non-Tyrosine Kinase Inhibitors Market Size 2015-2019, by Country, in Volume
Table Middle East & Africa Non-Tyrosine Kinase Inhibitors Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Non-Tyrosine Kinase Inhibitors Market Size 2015-2019, by Country, in Volume
Table Non-Tyrosine Kinase Inhibitors Market Forecast 2020-2025, by Region, in USD Million
Table Non-Tyrosine Kinase Inhibitors Market Forecast 2020-2025, by Region, in Volume
Table Price Factors List
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
